Literature DB >> 20703747

Survival tree and MELD to predict long term survival in liver transplantation waiting list.

Emília Matos do Nascimento1, Basilio de Bragança Pereira, Samanta Teixeira Basto, Joaquim Ribeiro Filho.   

Abstract

MELD score is a formula based on laboratory variables used as a predictor of short-term mortality index in cirrhotic patients. It is applied to allocate patients in liver transplantation waiting list in many countries. However, MELD score cutoff point accuracy to predict long term mortality has not been statistically evaluated. The aim of this study was to analyze the MELD score and other variables related to long-term mortality using a new model: the Survival Tree analysis. The variables considered in this study were obtained at the time of liver transplantation list enrollment. The graphical representation of the survival trees showed that MELD 16 was the most statistically significant mortality cutoff point. The results were compatible with the MELD cutoff point reported in the clinical literature. This methodology can be extended to identify significant cutoff points related to other diseases whose severity is not necessarily expressed by MELD.

Entities:  

Mesh:

Year:  2010        PMID: 20703747     DOI: 10.1007/s10916-010-9447-6

Source DB:  PubMed          Journal:  J Med Syst        ISSN: 0148-5598            Impact factor:   4.460


  11 in total

1.  Effect on outcome of the lengthening waiting list for liver transplantation.

Authors:  R Ransford; B Gunson; D Mayer; J Neuberger; E Christensen
Journal:  Gut       Date:  2000-09       Impact factor: 23.059

2.  Risk factors for liver transplantation waiting list mortality.

Authors:  Michael A Fink; S Roger Berry; Paul J Gow; Peter W Angus; Bao-Zhong Wang; Vijayaragavan Muralidharan; Christopher Christophi; Robert M Jones
Journal:  J Gastroenterol Hepatol       Date:  2007-01       Impact factor: 4.029

3.  Value of the MELD score for the assessment of pre- and post-liver transplantation survival.

Authors:  M Adler; E De Gendt; P Vereerstraeten; D Degré; N Bourgeois; N Boon; M Gelin; B Ickx; V Donckier
Journal:  Transplant Proc       Date:  2005 Jul-Aug       Impact factor: 1.066

4.  The MELD score may help to determine optimum time for liver transplantation.

Authors:  Y M Lee; M Fernandes; M Da Costa; K H Lee; D Sutedja; B C Tai; K C Tan; J Isaac; K Prabhakaran; S G Lim
Journal:  Transplant Proc       Date:  2004-12       Impact factor: 1.066

5.  Liver transplant recipient selection: MELD vs. clinical judgment.

Authors:  Michael A Fink; Peter W Angus; Paul J Gow; S Roger Berry; Bao-Zhong Wang; Vijayaragavan Muralidharan; Christopher Christophi; Robert M Jones
Journal:  Liver Transpl       Date:  2005-06       Impact factor: 5.799

Review 6.  A model to predict survival in patients with end-stage liver disease.

Authors:  P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

7.  Should liver transplantation in patients with model for end-stage liver disease scores <or= 14 be avoided? A decision analysis approach.

Authors:  James D Perkins; Jeffrey B Halldorson; Ramasamy Bakthavatsalam; Oren K Fix; Robert L Carithers; Jorge D Reyes
Journal:  Liver Transpl       Date:  2009-02       Impact factor: 5.799

8.  Clinical characterization and survival of adult patients awaiting liver transplantation in Chile.

Authors:  R Zapata; F Innocenti; E Sanhueza; R Humeres; H Rios; L Suarez; J M Palacios; M Rius; J Hepp
Journal:  Transplant Proc       Date:  2004 Jul-Aug       Impact factor: 1.066

9.  Liver transplant recipients mortality on the waiting list: long-term comparison to Child-Pugh classification and MELD.

Authors:  I F S F Boin; M I Leonardi; A O Pinto; R S R Leme; E Udo; R S B Stucchi; E C Soares; L S Leonardi
Journal:  Transplant Proc       Date:  2004-05       Impact factor: 1.066

10.  Application of a continuous disease severity score to the OPTN liver waiting list.

Authors:  E B Edwards; A M Harper
Journal:  Clin Transpl       Date:  2001
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.